Back to Search
NATALIE BOYER, PHARMD
PHARMD
Pharmacist
NPI: 1396624730Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.
PMID 19115222·Hepatology·2009
8-other
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.
PMID 19376603·J Hepatol·2009
8-other
Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin.
PMID 19578235·Antivir Ther·2009
3-trial
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4.
PMID 19671541·Gut·2009
8-other
Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody.
PMID 19076273·Liver Int·2009
3-trial
Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.
PMID 17895355·Gut·2008
8-other
Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
PMID 18593587·Gastroenterology·2008
8-other
Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
PMID 18164296·Gastroenterology·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1111 6TH AVE
DES MOINES, IA 50314 - Phone
- (515) 247-3121
Quick Facts
- NPI
- 1396624730
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile